{
    "id": 25278,
    "fullName": "PAXIP1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "PAXIP1 over exp indicates an over expression of the Paxip1 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 22976,
        "geneSymbol": "PAXIP1",
        "terms": [
            "PAXIP1",
            "CAGF28",
            "CAGF29",
            "PACIP1",
            "PAXIP1L",
            "PTIP",
            "TNRC2"
        ]
    },
    "variant": "over exp",
    "createDate": "08/23/2016",
    "updateDate": "07/30/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7913,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, lung cancer cells over expressing PAXIP1 were sensitive to treatment with Adavosertib (MK-1775) in culture, resulting in increased apoptotic activity (PMID: 27196765).",
            "molecularProfile": {
                "id": 26097,
                "profileName": "PAXIP1 over exp"
            },
            "therapy": {
                "id": 822,
                "therapyName": "Adavosertib",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6524,
                    "pubMedId": 27196765,
                    "title": "PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27196765"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7915,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, lung cancer cells over expressing PAXIP1 and negative for WEE1 did not respond to treatment with Adavosertib (MK-1775) in culture, demonstrating no effect on apoptotic activity (PMID: 27196765).",
            "molecularProfile": {
                "id": 26103,
                "profileName": "PAXIP1 over exp WEE1 neg"
            },
            "therapy": {
                "id": 822,
                "therapyName": "Adavosertib",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 6524,
                    "pubMedId": 27196765,
                    "title": "PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27196765"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7914,
            "approvalStatus": "Preclinical - Pdx & cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of Adavosertib (MK-1775) and Platinol (cisplatin) resulted in a synergistic effect when treating lung cancer cells in culture and a patient derived xenograft (PDX) model of lung cancer, both harboring over expression of PAXIP1 and WEE1 (PMID: 27196765).",
            "molecularProfile": {
                "id": 26104,
                "profileName": "PAXIP1 over exp WEE1 over exp"
            },
            "therapy": {
                "id": 1725,
                "therapyName": "Adavosertib + Cisplatin",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6524,
                    "pubMedId": 27196765,
                    "title": "PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27196765"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26097,
            "profileName": "PAXIP1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 26103,
            "profileName": "PAXIP1 over exp WEE1 neg",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 26104,
            "profileName": "PAXIP1 over exp WEE1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}